Galectin Therapeutics (GALT)
Galectin Therapeutics (GALT) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.
- GALT last traded at $2.81 on 2026-11-19, -5.70% for the session.
- Galectin Therapeutics: market cap $283.46M.
- Over the past year GALT returned -51.05%, with a year-to-date return of -32.45%.